Monofunctional chemotherapeutic alkylating drugs produce 3-methyladenine in dsDNA

Stable Identifier
R-HSA-9730736
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
nucleoplasm
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Monofunctional chemotherapeutic alkylating drugs produce 3-methyladenine in dsDNA
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Alkylating chemotherapeutic drugs from the triazene group, dacarbazine (Braybrook et al. 2000), temozolomide (Deans and Tisdale 1992), and streptozocin (streptozotocin) (Bennett and Pegg 1981 - study was performed in rats), and probably procarbazine, produce 3-metyladenine adducts on DNA (3meA-dsDNA) (reviewed by Fu et al. 2012).
Literature References
PubMed ID Title Journal Year
1562991 Antitumour imidazotetrazines XXVIII 3-methyladenine DNA glycosylase activity in cell lines sensitive and resistant to temozolomide

Tisdale, MJ, Deans, B

Cancer Lett 1992
10663625 Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen

Stratford, IJ, Crawley, JE, Harris, AL, Propper, DJ, O'Byrne, KJ, Braybrooke, JP, Shuker, DE, Houlbrook, S, Talbot, DC

Cancer Chemother Pharmacol 2000
Participants
Input
Output
Participates
as an event of
Inferred From
Streptozocin (streptozotocin) produces 3-methyladenine in dsDNA (Rattus norvegicus)
Authored
Orlic-Milacic, M  (2021-05-11)
Reviewed
Kadambat Nair, S  (2021-07-28)
Created
Orlic-Milacic, M  (2021-05-10)
Cite Us!